Implications of Soluble C-type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with Thrombosis
Thrombosis and Haemostasis · 01.02.2026 · 126 (02) · 136-145
DOI: 10.1055/a-2572-1170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Thrombosis and Haemostasis, erschienen am 01.02.2026. Verfasst von Hideo Wada und 13 weiteren Autor:innen. Beteiligte Einrichtung: Department of General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Japan. Hauptthemen laut MEDLINE: COVID-19, Thrombosis, Lectins, C-Type. Die Arbeit nennt 69 Literaturangaben. Gefördert von: the Ministry of Health, Labor and Welfare of Japan, Ministry of Health, Labor and Welfare of Japan.
Abstract (Originalsprache)
Coronavirus disease 2019 (COVID-19) is often associated with thrombosis. Elevated levels of soluble C-type lectin-like receptor 2 (sCLEC-2), a biomarker for platelet activation, have been reported in COVID-19. Therefore, we examined the behavior of sCLEC-2 levels and their relationship with thrombosis. The clinical course of inflammatory and thrombotic biomarkers was assessed in 271 patients with COVID-19. Inflammatory biomarkers such as C-reactive protein, procalcitonin, and presepsin levels were significantly increased in patients with COVID-19, and these behaviors differed among the clinical course or stages. The plasma D-dimer levels increased slightly and gradually. Platelet counts were within the normal range, and plasma sCLEC-2 levels were markedly increased in most patients with COVID-19. There were 17 patients with thrombosis in this study. Although there was no significant difference in various biomarkers between COVID-19 patients with and without thrombosis, the super formula of sCLEC-2xD-dimer/platelet count in patients with thrombosis was significantly higher than in those without thrombosis. Furthermore, this super formula was significantly higher in COVID-19 patients with severe or critical illness than in those with mild or moderate illness. Elevation of the super formula of sCLEC-2xD-dimer/platelet count was associated with the thrombosis in patients with COVID-19 suggesting the thrombosis in COVID-19 may be caused by the development of microthrombosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of General Medicine, Mie Prefectural General Medical Center, Yokkaichi, Japan.
- Department of Central Laboratory, Mie Prefectural General Medical Center, Yokkaichi, Japan.
- Department of Neurology, Mie Prefectural General Medical Center, Yokkaichi, Japan.
- Department of Gastroenterology, Mie Prefectural General Medical Center, Yokkaichi, Japan.
- Department of Cardiovascular Medicine, Mie Prefectural General Medical Center, Yokkaichi, Japan.
- Department of Emergency and Critical Care Center, Mie Prefectural General Medical Center, Yokkaichi, Japan.
Förderung
- the Ministry of Health, Labor and Welfare of Japan
- Ministry of Health, Labor and Welfare of Japan
Zitieren
APA
Wada, H., Shiraki, K., Ichikawa, Y., Ito, N., Inoue, H., Moritani, I., Masuda, J., Yamamoto, A., Tomida, M., Yoshida, M., Kawamura, M., Shimaoka, M., Iba, T., & Shimpo, H. (2026). Implications of Soluble C-type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with Thrombosis. Thrombosis and Haemostasis, 126(02), 136-145. https://doi.org/10.1055/a-2572-1170
Vancouver
Wada H, Shiraki K, Ichikawa Y, Ito N, Inoue H, Moritani I, et al. Implications of Soluble C-type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with Thrombosis. Thrombosis and Haemostasis. 2026;126(02):136-145. doi:10.1055/a-2572-1170
BibTeX
@article{Wada2026,
author = {Wada, Hideo and Shiraki, Katsuya and Ichikawa, Yuhuko and Ito, Nobuo and Inoue, Hidekazu and Moritani, Isao and Masuda, Jun and Yamamoto, Akitaka and Tomida, Masaki and Yoshida, Masamichi and Kawamura, Masahide and Shimaoka, Motomu and Iba, Toshiaki and Shimpo, Hideto},
title = {Implications of Soluble C-type Lectin-Like Receptor 2 Levels in Patients with Coronavirus Disease 2019-Associated with Thrombosis},
journal = {Thrombosis and Haemostasis},
year = {2026},
volume = {126},
number = {02},
pages = {136--145},
doi = {10.1055/a-2572-1170}
}
EUVIMED